APA (7th ed.) Citation

Dai, Q., Li, Y., Wang, M., Li, Y., & Li, J. (2020). TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Experimental & Therapeutic Medicine, 19(4), 3009. https://doi.org/10.3892/etm.2020.8557

Chicago Style (17th ed.) Citation

Dai, Qiaomei, Yaozhang Li, Meiqiao Wang, Yang Li, and Ji Li. "TlR2 and TlR4 Are Involved in the Treatment of Rheumatoid Arthritis Synovial Fibroblasts with a Medicated Serum of Asarinin Through Inhibition of Th1/Th17 Cytokines." Experimental & Therapeutic Medicine 19, no. 4 (2020): 3009. https://doi.org/10.3892/etm.2020.8557.

MLA (9th ed.) Citation

Dai, Qiaomei, et al. "TlR2 and TlR4 Are Involved in the Treatment of Rheumatoid Arthritis Synovial Fibroblasts with a Medicated Serum of Asarinin Through Inhibition of Th1/Th17 Cytokines." Experimental & Therapeutic Medicine, vol. 19, no. 4, 2020, p. 3009, https://doi.org/10.3892/etm.2020.8557.